
Corsmed SBR is a post-processing software medical device under development, intended to generate multiple synthetic contrast-weighted images of the brain from a structured multi-sequence MRI acquisition.
Join the technical updates listSBR is designed to analyze brain MR images acquired with clinically available sequences. The SBR acquisition protocol consists of standardized scans on a clinical MRI system and will use vendor product implementations and standard Cartesian encoding.
Leveraging physics-based methods, SBR is designed to estimate voxel-wise tissue properties from the acquired data and will compute synthetic images simulating the contrast behavior of standard clinical sequences.
The methods underpinning SBR are grounded in over a decade of peer-reviewed research in MRI simulation, including foundational work on cloud-based physics simulation and quantitative tissue parameter estimation.
The same simulation foundations power Corsmed's MRI training platform, used by universities, colleges, and hospitals worldwide.
The device is currently in late-stage development. Verification of software, algorithms, and system integration has been substantially completed. SBR is in the process of presenting its device and validation plan to the U.S. Food and Drug Administration.
SBR is an investigational device under development.
Sign up to receive technical updates.
This list is for technical updates. Corsmed does not solicit clinical or commercial use of investigational devices.
The Corsmed SBR device described on this page is an investigational device under development. It has not received FDA clearance or CE marking and is not available for clinical use, sale, or distribution in any region. Statements regarding development progress reflect Corsmed's internal assessment and have not been validated in clinical settings.